483 Cadila Pharmaceuticals May 2018

483 Cadila Pharmaceuticals May 2018

Linda Thai FDA$119.00 - Available Now

FDA investigators audited the Cadila Pharmaceuticals - Ahmedabad, India facility and issued inspectional observations (via FDA 483) on 03 May 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 03 May 2018
  • Location: Ahmedabad, India
  • FEI: 3007684569
Add To Cart